Net Cash Provided by (Used in) Financing Activities of DarioHealth Corp. from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
DarioHealth Corp. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
  • DarioHealth Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $6,815,000, a 66% decline year-over-year.
  • DarioHealth Corp. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $38,531,000, a 111% increase from 2023.
  • DarioHealth Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $18,253,000, a 71% decline from 2022.
  • DarioHealth Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $61,940,000, a 5.8% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

DarioHealth Corp. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,815,000 -$13,391,000 -66% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $20,206,000 +$21,595,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $1,389,000 -$39,412,000 -104% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $38,023,000 -$27,688,000 -42% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $65,711,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2019 $0 -$6,034,000 -100% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q1 2018 $6,034,000 +$1,218,000 +25% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q1 2017 $4,816,000 -$2,912,000 -38% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $7,728,000 01 Jan 2016 31 Mar 2016 10-Q 19 Mar 2018 2017 Q1
Q1 2013 $498,026 -$417,819 -46% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q1 2012 $915,845 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1

DarioHealth Corp. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $38,531,000 +$20,278,000 +111% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2025 2024 FY
2023 $18,253,000 -$43,687,000 -71% 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2025 2024 FY
2022 $61,940,000 -$3,826,000 -5.8% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $65,766,000 +$38,218,000 +139% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $27,548,000 +$2,301,000 +9.1% 01 Jan 2020 31 Dec 2020 10-K 22 Mar 2022 2021 FY
2019 $25,247,000 +$6,504,000 +35% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $18,743,000 +$5,280,000 +39% 01 Jan 2018 31 Dec 2018 10-K 17 Mar 2020 2019 FY
2017 $13,463,000 +$5,715,000 +74% 01 Jan 2017 31 Dec 2017 10-K 25 Mar 2019 2018 FY
2016 $7,748,000 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.